- Filed
- Mar 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 46.52M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 46.27M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 32.85M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 29.37M sh |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −10.06M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −5.27M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | 14.2M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | 10.79M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | 13.01M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2024 | 3.55M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | 14.86M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | 17.71M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | 23.63M |
| Stockholders Equity restated | Q3 2026 · Jan 31, 2025 | 24.95M |
| Stockholders Equity restated | Q3 2026 · Oct 31, 2024 | 31.89M |
| Stockholders Equity restated | Q3 2026 · Apr 30, 2024 | 35.68M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | 5.03M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | 9.01M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | 8.13M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | 20.82M |
| Current Assets | Q3 2026 · Jan 31, 2026 | 18.82M |
| Current Assets | Q3 2026 · Apr 30, 2025 | 18.75M |
| Total Assets | Q3 2026 · Jan 31, 2026 | 22.99M |
| Total Assets | Q3 2026 · Apr 30, 2025 | 44.44M |
| Rd Expense | Q3 2026 · Jan 31, 2026 | 1.21M |
| Rd Expense | Q3 2026 · Jan 31, 2026 | 3.36M |
| Rd Expense restated | Q3 2026 · Jan 31, 2025 | 914K |
| Rd Expense restated | Q3 2026 · Jan 31, 2025 | 3.39M |
| Net Income | Q3 2026 · Jan 31, 2026 | −3.93M |
| Net Income | Q3 2026 · Jan 31, 2026 | −10.08M |
| Net Income | Q3 2026 · Jan 31, 2025 | −21.52M |
| Net Income | Q3 2026 · Jan 31, 2025 | −28.07M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | 2.46M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | 6.65M |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | 1.76M |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | 4.14M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | 1.69M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | 4.79M |
| Cost Of Revenue restated | Q3 2026 · Jan 31, 2025 | 967K |
| Cost Of Revenue restated | Q3 2026 · Jan 31, 2025 | 3.74M |
| Revenue | Q3 2026 · Jan 31, 2026 | 4.16M |
| Revenue | Q3 2026 · Jan 31, 2026 | 11.44M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | 2.73M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | 7.88M |